Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Choi

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Journal of Medicinal Chemistry|June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of ToxoplasmosisRama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
Plos One|February 6, 2013
Combining functional and structural genomics to sample the essential Burkholderia structomeLoren Baugh, Larry A Gallagher, Rapatbhorn Patrapuvich, et al.
Gut|July 12, 2018
Evolutionary history of human colitis-associated colorectal cancerAnn-Marie Baker, William Cross, Kit Curtius, et al.
ACS Medicinal Chemistry Letters|December 23, 2015
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of <i>Toxoplasma gondii</i> CDPK1Wenlin Huang, Kayode K Ojo, Zhongsheng Zhang, et al.
Veterinary Parasitology|January 8, 2021
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseasesWesley C Van Voorhis, Matthew A Hulverson, Ryan Choi, et al.
International Journal for Parasitology|September 14, 2017
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosisMatthew A Hulverson, Ryan Choi, Samuel L M Arnold, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate CancerTakuma Uo, Kayode K Ojo, Cynthia C Sprenger, et al.
International Journal for Parasitology|April 1, 2020
Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learnedRyan Choi, Matthew A Hulverson, Wenlin Huang, et al.
Molecular Cancer Therapeutics|March 20, 2024
A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate CancerTakuma Uo, Kayode K Ojo, Cynthia C T Sprenger, et al.
Tuberculosis (Edinburgh, Scotland)|January 24, 2015
Increasing the structural coverage of tuberculosis drug targetsLoren Baugh, Isabelle Phan, Darren W Begley, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Journal of Medicinal Chemistry|June 17, 2016
Development of an Orally Available and Central Nervous System (CNS) Penetrant Toxoplasma gondii Calcium-Dependent Protein Kinase 1 (TgCDPK1) Inhibitor with Minimal Human Ether-a-go-go-Related Gene (hERG) Activity for the Treatment of ToxoplasmosisRama Subba Rao Vidadala, Kasey L Rivas, Kayode K Ojo, et al.
Plos One|February 6, 2013
Combining functional and structural genomics to sample the essential Burkholderia structomeLoren Baugh, Larry A Gallagher, Rapatbhorn Patrapuvich, et al.
Gut|July 12, 2018
Evolutionary history of human colitis-associated colorectal cancerAnn-Marie Baker, William Cross, Kit Curtius, et al.
ACS Medicinal Chemistry Letters|December 23, 2015
SAR Studies of 5-Aminopyrazole-4-carboxamide Analogues as Potent and Selective Inhibitors of <i>Toxoplasma gondii</i> CDPK1Wenlin Huang, Kayode K Ojo, Zhongsheng Zhang, et al.
Veterinary Parasitology|January 8, 2021
One health therapeutics: Target-Based drug development for cryptosporidiosis and other apicomplexa diseasesWesley C Van Voorhis, Matthew A Hulverson, Ryan Choi, et al.
International Journal for Parasitology|September 14, 2017
Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosisMatthew A Hulverson, Ryan Choi, Samuel L M Arnold, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
A Compound that Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate CancerTakuma Uo, Kayode K Ojo, Cynthia C Sprenger, et al.
International Journal for Parasitology|April 1, 2020
Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learnedRyan Choi, Matthew A Hulverson, Wenlin Huang, et al.
Molecular Cancer Therapeutics|March 20, 2024
A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate CancerTakuma Uo, Kayode K Ojo, Cynthia C T Sprenger, et al.
Tuberculosis (Edinburgh, Scotland)|January 24, 2015
Increasing the structural coverage of tuberculosis drug targetsLoren Baugh, Isabelle Phan, Darren W Begley, et al.
Pageof 10